Tag: Modeling and Simulation

QSP Model of Hematopoiesis in MDS and AML

See how a mechanistic QSP platform captures disease progression and treatment response to enable better decisions in hematologic drug development.…

Drug development

ADC Development and Market Access

Optimizing ADC value beyond approval through model-informed strategies Originally aired: Thursday, April 2, 2026 As antibody–drug conjugates (ADCs) move from…

Drug development

The Path to Better Clinical Outcomes

Comprehensive data integration to bring together compound properties, in vitro assay results, preclinical PK data, and mechanistic understanding in a…

Drug development

Adaptive clinical trials in oncology

Leveraging adaptive clinical trial designs in oncology allows researchers to adjust predefined study elements based on accumulating data, such as…

Drug development

Modeling and Simulation and RWE in Clinical Trial Diversity Planning

Due to the highly controlled settings of clinical trials, enrolled subjects may not be fully representative in age, gender, ethnicity,…

Drug development